Correlation Between ImmunoCellular Therapeutics and Vg Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ImmunoCellular Therapeutics and Vg Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoCellular Therapeutics and Vg Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoCellular Therapeutics and Vg Life Sciences, you can compare the effects of market volatilities on ImmunoCellular Therapeutics and Vg Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoCellular Therapeutics with a short position of Vg Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoCellular Therapeutics and Vg Life.

Diversification Opportunities for ImmunoCellular Therapeutics and Vg Life

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ImmunoCellular and VGLS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and Vg Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vg Life Sciences and ImmunoCellular Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoCellular Therapeutics are associated (or correlated) with Vg Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vg Life Sciences has no effect on the direction of ImmunoCellular Therapeutics i.e., ImmunoCellular Therapeutics and Vg Life go up and down completely randomly.

Pair Corralation between ImmunoCellular Therapeutics and Vg Life

If you would invest  0.00  in Vg Life Sciences on December 4, 2024 and sell it today you would earn a total of  0.00  from holding Vg Life Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

ImmunoCellular Therapeutics  vs.  Vg Life Sciences

 Performance 
       Timeline  
ImmunoCellular Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ImmunoCellular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ImmunoCellular Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Vg Life Sciences 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

ImmunoCellular Therapeutics and Vg Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ImmunoCellular Therapeutics and Vg Life

The main advantage of trading using opposite ImmunoCellular Therapeutics and Vg Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoCellular Therapeutics position performs unexpectedly, Vg Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vg Life will offset losses from the drop in Vg Life's long position.
The idea behind ImmunoCellular Therapeutics and Vg Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities